Skip to content

DBV Technologies DBVT Expenses by Nature — Operating Expenses

Similar metrics at other companies

Catalyst Pharmaceutical logo
CPRXOperating Expense
$76.16M-2.4%
Avalo Therapeutics logo
AVTXTotal costs & expenses
$20.9M+42.5%
Veradermics
 logo
MANETotal Operating Expenses
$29.86M+131%
Spyre Therapeutics, Inc. logo
SYRETotal Operating Expenses
$45.64M-14.8%
Hannon Armstrong Sustainable Infrastructure Capital logo
HASIOperating And Non Operating Expenses
$149.49M+45.3%
CG Oncology logo
CGONTotal costs & expenses
$67.47M+59.7%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+269%
Enterprise value$700.21M+188%
P/S159.6×+89.0×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's expenses by nature — operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's expenses by nature — operating expenses?
DBV Technologies (DBVT) reported expenses by nature — operating expenses of $14M in Q1 2026.
How has DBV Technologies's expenses by nature — operating expenses changed year-over-year?
DBV Technologies's expenses by nature — operating expenses increased by 79.5% year-over-year, from $7.8M to $14M.
What is the long-term trend for DBV Technologies's expenses by nature — operating expenses?
Over 4 years (2021 to 2025), DBV Technologies's expenses by nature — operating expenses has grown at a 6.5% compound annual growth rate (CAGR), from $31.14M to $40.04M.
What does expenses by nature — operating expenses mean?
Captures the aggregate costs incurred in the normal course of business to support research, development, and administrative functions. This metric provides a comprehensive view of the company's burn rate and operational efficiency. It is essential for evaluating the company's ability to manage its resources while advancing its clinical-stage pipeline.